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Abstract
The Black Swan Theory was described by Nassim Nicholas Taleb in his book “The Black Swan”. This theory refers to
“high-impact, hard-to-predict, and rare events beyond the realm of normal expectations”. According to Taleb’s
criteria, a Black Swan Event is a surprise, it has a major impact and after the fact, the event is rationalized by
hindsight, as if it had been expected. For most of human history centenarians were a rare and unpredictable
phenomenon. The improvements of the social-environmental conditions, of medical care, and the quality of life
caused a general improvement of the health status of the population and a consequent reduction of the overall
morbidity and mortality, resulting in an overall increase of life expectancy. The study of centenarians and
supercentenarians had the objective to consider this black swan and to evaluate the health, welfare, social and
economic consequences of this phenomenon.
Introduction
The term “Black Swan” comes from the 17th century
European belief that the existence of a black swan was
impossible. After a hundred years black swans were dis-
covered in Western Australia and so the term started to
indicate that a perceived impossibility may come to pass
[1]. The Black Swan Theory refers to high-impact, hard-
to-predict, and rare events beyond the realm of normal
expectations. The theory was described by Nassim Nicho-
las Taleb in his 2007 book “The Black Swan”. Taleb
regards almost all major scientific discoveries, historical
events, and artistic accomplishments as “black swans” —
undirected and unpredicted [1]. Healthy centenarians are
a living example of successful aging free from chronic dis-
eases causing permanent injuries and from reduced mental
and physical functions [2]. For most of human history cen-
tenarians were a rare and unpredictable phenomenon [3].
Although numerous studies have characterized the
centenarian phenotype according to metabolic, endocrine,
immune, physical and cognitive functions, little work has
emerged that describes the health histories associated with
exceptional longevity [4-7]. The improvements of the
social-environmental conditions, of medical care, and the
quality of life caused a general improvement of the health
status of the population and a consequent reduction of the
overall morbidity and mortality, resulting in an overall
increase of life expectancy. Around the 1970s, the progres-
sive decline of mortality (1–2% per year) in individuals
over 80 years old has increased in all industrialized coun-
tries, so that the number of centenarians has augmented
about 20-fold [8]. The term “supercentenarians” describes
the subjects who had reached 110 years of age, in a vali-
dated manner. Their prevalence is estimated to be
0.3-0.5% of the centenarians [9]. Supercentenarians should
be considered as exceptional individuals having a particu-
larly efficient network, able for exceptional performances
to slow down the numerous pathological conditions deter-
mining the aging process, and stimulating the factors
resulting in resistance against diseases, increasing this way
the survival [10].
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Factors that influence the longevity
Many studies suggested that some factors are important to
longevity in centenarians: 1) heredity, role of specific genes
and family history [11] 2) general health and lifestyle, i.e.
weight, diet, amount of physical exercise, smoking habits
[12,13] 3) education level [14] 4) personality [15,16]. The
largest population of centenarians are widowed women
[17]. The Okinawa Centenarians Study (OCS) has shown
several different factors that have contributed to the large
number of centenarians there. These factors are: 1) a diet
based mainly on grains, fish and vegetables instead of
meat, eggs, and dairy products; 2) low-stress lifestyles,
compared to the mainland inhabitants of Japan; 3) caring
community and active work until an older age than the
average age in other countries; 5) a strong role of spiritual-
ity, with involvement in spiritual matters and prayer that
ease the mind of stress and problems [18-20]. Human
longevity is due to genetics, age, sex, ethnicity and envir-
onment of the study population. [21-23]. Whether
prolonged caloric restriction (CR) increases average or
maximum lifespan or promotes a more youthful physiol-
ogy in humans at advanced ages is not yet known. How-
ever, available epidemiological evidence indicates that CR
may already have contributed to an extension of average
and maximum life span in older Okinawans and appears
to have lowered risk for age associated chronic diseases in
other human populations [24].
General conditions of centenarians
Centenarians display extremely variable clinical condi-
tions. On the one hand, there are frail individuals among
them with polypathologies, being an expression of the
terminal deterioration related to the progressive increase
of the medium life span. On the other hand, there are
subjects without particular disease conditions or cogni-
tive disorders. Some of them present, however, signs of
the advanced aging process, such as hypoacusia, visual
disorders, limited locomotor capacities, etc. [25,26]. A
consortium of 20 university departments of geriatrics and
gerontology conducted the Italian Multicentric Study on
Centenarians (IMUSCE), in order to assess the socio-eco-
nomic, clinical and biological conditions of Italian cente-
narians. According to the IMUSCE criteria, based on
psychophysical status and autonomy, centenarians can be
classified in three groups as follows: Group A: centenar-
ians in good health status; Group B: centenarians in an
intermediate health status. Group C: centenarians in bad
health status. Group A represented 20.0% of the total
pool, Group B amounted to 33.4%, and the Group C was
46.6%. The centenarians of Group A presented normal
activities of daily living (ADL) values, and 47.9% of them
were autosufficient in all functions; 5.7% of them were
independent in all instrumental activities of daily living
(IADL) items. These data confirm that the centenarians
of Group A are free of invalidating chronic diseases, are
autonomous, maintain good physical and cognitive capa-
cities, however, have not maintained any social or pro-
ductive activities. Therefore, they cannot be considered
as prototypes of successful aging [26].
Supercentenarians
The supercentenarians display an elevated percentual
occurrence of alterations which do not have a determinis-
tic role in the survival: (cataract, osteoporosis, bone frac-
tures, etc.), and a low prevalence of more significant,
chronic degenerative pathologies. Generally they reach
100 years of age in good health, and only after 105 years of
age start to manifest age-dependent alterations with high
variability [9]. Usually their death cause is not correlated
to the typical pathologies of aged people, such as cancer,
stroke, myocardial infarction, etc. [22,27]. The decreased
prevalence of various pathologies widely documented in
the centenarians, as compared to the elderly, seems to be
present also in the supercentenarians, compared to the
centenarians. Even the dementia of various clinical aspects,
which is the only disease condition more frequent in the
elderly than in the centenarians [28] seems to be of lower
prevalence in the supercentenarians, as compared to the
centenarians [9].
Immunity and centenarians
Ageing of the immune system relates to both innate and
adaptive immunity although the innate one is regarded to
be better preserved than adaptive one [29-31]. The age-
related alterations of adaptive immunity include a decline
of naive T lymphocytes and accumulation of memory/
effector T cells, reduction in the number of B cells, up-
regulation of the inflammatory responses and dysregula-
tion of the Th1/Th2 system. The increased number of
Natural Killer (NK) cells with well-preserved cytotoxic
function is a characteristic feature of the innate part of
ageing immune system [32]. The process of successful
ageing, (i.e. ageing in good psychophysical conditions)
[33] is immunologically characterized by preserved lym-
phoproliferative responses and NK cytotoxic activity as
well as conserved antigen presentation [34]. Healthy cen-
tenarians show normal number of T lymphocytes,
increased production of immunoglobulins, lack of organ-
specific autoantibodies, well preserved NK activity and
retained proliferative capability of T lymphocytes [35].
The remodelling of the immune system occurring with
age is capable of creating a hostile environment for the
growth of cancer cells in centenarians [36]. In fact an
age-dependent increase of CD8+ CD28 – T cells having
a high cytotoxic capacity, both in percentage and abso-
lute number, has been found in elderly people and cente-
narians [37,38]. Moreover, an increased number and
percentage of NK cells (CD16+, CD56+, CD57+) has
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been found in centenarians with the highest NK function
and number of NK cells have preserved endocrine condi-
tions and muscle mass [39,40]. Thus the increase with
the age of cells with NK features could cause a prevailing
of the innate immunity in the oldest old, which might
create an unfavourable environment for neoplastic
growth [41-44].
Hormonal status in centenarians
It is well known that physiological changes in the neu-
roendocrine system may be related to the process of
aging. A study revealed several differences in the neu-
roendocrine and metabolic status of centenarians, com-
pared with other age groups, including the lowest serum
concentrations of leptin, insulin and T3, and the highest
values for prolactin. LH and FSH levels were comparable
with those in the elderly and postmenopausal groups, but
they were significantly higher than in younger subjects.
GH concentrations in centenarians were lower than in
younger women. It has been also demonstrated that BMI
in centenarian subjects does not differ significantly from
BMI of younger subjects but it is lower than that found
in early elderly subjects [45]. Several studies in humans
have shown that longevity is associated with a significant
improvement in glucose handling - mainly, a rise in insu-
lin sensitivity and a decline in plasma insulin-like growth
factor I levels [46]. Moreover Paolisso et al. demonstrated
that centenarians compared with aged subjects had a pre-
served glucose tolerance and insulin action despite to the
decline in insulin action due to advancing age [47].As
regards thyroid activity, contrasting results have been
revealed. In fact it has been showed an age-related
decline of the TSH levels and a significant increase of the
reverse T3 (rT3) concentrations in centenarians by com-
parison to old controls. These findings may be related to
an age-dependent reduction of the 5’-deiodinase activity
[48]. Other studies showed that the distribution of serum
TSH shifts progressively to higher concentrations with
age, appearing to be a continuum that extends even to
people with exceptional longevity. The inverse correla-
tion between TSH and FT4 in this study populations sug-
gests that changes in negative feedback may contribute to
exceptional longevity [49].
Energy, carnitine and antioxidants
L-carnitine and its short-chain esters facilitate long-chain
fatty acid transport across the inner mitochondrial mem-
brane for b-oxidation. It thereby promotes energy avail-
ability and prevents toxic accumulation of long-chain fatty
acids [50,51]. Acetyl-L-carnitine (ALC) is an ester of
L-carnitine, a trimethylated aminoacid; it is synthesized in
the central nervous system (CNS), liver, and kidney via the
action of ALC transferase and stored in skeletal muscle,
both in the free form and as an ester with acetyl groups
[52]. ALC concentration is age and gender dependent.
ALC controls the transport of long-chain fatty acids in
mitochondria and then their b-oxidation, and it ensures
the minimum necessary level of acetyl-coenzyme A
required for energetic cellular metabolism [53]. ALC is the
most abundant L-carnitine ester in the nervous system,
being fundamental for lipid metabolism and polyunsatu-
rated fatty acids synthesis in neuronal membrane. It is also
able to improve neuronal metabolism by increasing the
use of glucose and eliminating oxidative metabolites and
to enhance the activities of electron transport chain
enzymes [54-56]. Caloric restriction, low levels of oxidative
stress and changes in glucose handling seem to be the
most compelling factors relating longevity and metabo-
lism. Caloric restriction has been shown to reduce body
temperature, improve insulin sensitivity (by lowering fast-
ing plasma glucose and insulin levels and improving insu-
lin action), lower fasting plasma free insulin-like growth
factor I (IGF-I) and dehydroepiandrosterone (DHEA)
levels and improve thyroid activity. Together, these actions
result in two main effects: lowering energy production in
the mitochondrial complex and minimizing DNA damage
and thus genomic instability. With regard to energy pro-
duction in the mitochondrial complex, an ad libitum diet
is associated with enhanced production of reactive oxygen
substances (ROSs) that activate several cascade mechan-
isms resulting in impairment of enzyme activity. In con-
trast, caloric restriction lowers mitochondrial activity,
which decreases the production of ROSs, leading to a sec-
ondary improvement in intracellular metabolism. Cellular
aging is slowed by decreasing the production of ROSs,
which leads to reduced DNA damage [57]. The principal
target of ALC’s action is mitochondrial DNA, on which it
exerts an antioxidant effect and stimulates mitochondrial
DNA synthesis [58]. Moreover ALC supplementation may
reduced significantly both physical and mental fatigue and
improved physical activity and cognitive status [59]. Var-
ious mechanism can explain the therapeutic effect of ALC,
such as the beneficial effects of ALC on mitochondrial
alterations and on the progressive impairment of neuro-
transmission, the correction on deficits of cellular energy
supply. Carnitine and its derivative, ALC affect other cellu-
lar functions, including maintenance of key proteins and
lipids of the mitochondria at sufficient levels, proper mem-
brane orientation and maximum energy production [60].
Cardiovascular risk factors and oxidative stress in
centenarians
Several studies have shown that centenarians have better
cardiovascular risk profiles compared to younger old
people. Some reports have revealed that cardiovascular
diseases (i.e. hypertension, diabetes, angina and/or
myocardial infarction) are less common in centenarians
respect to 70 and 80 years old persons [61]. Centenarians
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have high levels of the natural antioxidants vitamins A and
E [62] that may be protective from atherosclerosis. But
they present enhanced coagulation enzyme activity, ele-
vated plasma fibrinogen and homocysteine levels, which
represent thrombotic risk factors for middle-aged indivi-
duals [63-66]. Moreover centenarians present elevated
levels of IL-18, which is a proinflammatory cytokine that
appears to be involved in atherosclerosis [67]. Gangemi et
al demonstrated the apparent paradox of elevated serum
IL-18 with no vascular signs in centenarians can be
explained by the presence of high IL-18 binding protein
levels (a protein that neutralizes the activity of IL-18) in
these subjects [68]. A study showed that indices of oxida-
tive stress (reaction products of malondialdehyde with
thiobarbituric acid (TBARS) and lipid hydroperoxides
(LPO), were lower in centenarians than in aged subjects.
In contrast, reduced/oxidized glutathione ratio (GSH/
GSSG) and plasma concentrations of antioxidant defenses
(plasma vitamin E and C) were more elevated in centenar-
ians than in aged subjects [69]. A study by Rabini et al
showed that there is an age-associated trend in the platelet
membrane concentrations of a biomarker of oxidative
stress (MDA), but centenarians showed platelet membrane
concentrations of MDA lower than elderly subjects and
similar to the levels found in an adult group. These differ-
ence is associated with a decreased platelet activation and
therefore might exert a protective role against cardiovas-
cular accidents, as platelet activation is a key event in the
initiation and progression of arteriosclerosis [70]. As
regards the lipids analysis in centenarian populations, con-
trasting results have been revealed. There are findings
about decreased or increased values of total cholesterol,
LDL- and HDL-cholesterol, triglycerides, ApoB100, and
ApoA1. As regards the serum levels of lipoprotein(a),
increased or unchanged values have been observed [71-73]
Total cholesterol decreased with advancing age, but high-
density lipoprotein maintained at high levels, consistent
with a previously reported lipoprotein phenotype of excep-
tional longevity in centenarians [74]. Receputo et al.
observed noted that total cholesterol values in a group of
male centenarians were within the normal range and were
significantly lower than in elderly male subjects [75].
These data support the protective role of low total choles-
terol values also with regard to longevity [76]. Even if
blood pressure progressively increases with age [77],
Gareri et al. have not found it in centenarians [78]. The
lesser frequency of hypertension in centenarians certainly
depends on genetic and constitutional factors, but also
their style of life and alimentary habits (decreased sodium
intake, increase of calcium and potassium intake) could be
determinant [79,80]. The extraordinary longevity of cente-
narians can not be explained even if hypertension, that is a
risk factor for cardiovascular and cerebrovascular morbid-
ity and mortality, is present for all the ages of life [78].
Cancer and longevity
Centenarians appear to “outlive” the risks for many of
those conditions that are common causes of death for
those who die in their 70s, 80s and 90s, such as cancer
and myocardial infarction [81]. The analysis of demo-
graphic data indicates that cancer incidence and mortal-
ity show a levelling off around the age of 85-90 years, and
suggests that oldest old people and centenarians are
protected from cancer onset and progression [82].
Accordingly, studies on autopsy records revealed that
long-lived people and centenarians are characterised by a
lower than expected incidence, metastatic rate and
mortality for cancer [83,84]. Moreover an autoptic study
performed on 140 centenarians, has revealed the pre-
sence of various types of cancer in 16.3%, as compared to
the average elderly showing 39.0%, and there was a lower
aggressivity of metastases, too (24.0% vs. 55.0 %) [85].
The complex relationship between the change of apopto-
sis susceptibility with age and cancer prevalence in the
oldest old can predict that gene products and poly-
morphisms of genes are involved in apoptosis [86]. A
particular attention deserves the relationship between
apoptosis, its age-related changes, and cancer susceptibil-
ity in the oldest old [87]. ApoJ is a gene which appears to
play an important role in aging, apoptosis and cancer but
whose role is still unclear [88]. In cancer cells, this gene
confers cytoprotection by inhibiting apoptosis, although
there are reports indicating a pro-apoptotic function of
ApoJ in other tumor-derived cell lines [89] In recent
years the extensive genotypisation of centenarians led to
study polymorphisms which are claimed to be able to
affect individual’s cancer susceptibility, namely those
located in the anti-oncogene p53, in the oncogene
HRAS1, in asset of genes involved in carcinogens meta-
bolism, i.e. cytochrome P450 oxidases (CYP) and glu-
tathione transferases (GST), in a gene whose mutations
are risk factor for breast cancer (BRCA1) and in a gene
whose activity is a potential risk factor for prostate cancer
(SRD5A2) [41] Nevertheless it is difficult to interpret the
net difference in the prevalence of cancer in extreme
longevity: in the Okinawa Centenarian Study (OCS) [22],
cancer is absent, while in the New England Centenarian
Study (NECS) [27], it is present in 25% of the supercente-
narians, however, all of them were previously treated, and
none of them were active. This is a condition which justi-
fies the presence of cancer in the supercentenarians.
Some of centenarians had been affected by cancer in
their life, but they survived, even though during an his-
torical period when cancer treatment was not as devel-
oped as in the present days [90,91]. Thus is reasonable to
conclude that centenarians are people endowed with a
peculiar resistance to cancer [41] The relationship
between polymorphism associated with cancer suscept-
ibility and human longevity is complex and the studies so
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far performed provided insights on some mechanisms
involved in human longevity. At the moment the role of
the immunosenescence on cancer incidence is an extre-
mely debated argument [92]. It has been suggested that
the immunosenescence is not an inevitable and progres-
sive decline of all immune functions, but rather the result
of a continuous remodelling process in which several
functions are reduced, others increased, while others
remain unchanged [93]. Studies of the immune system of
centenarians, spotlighted that one of the main factors of
longevity may be represented by well functioning
immune system which allows the prevention of the main
age-related pathologies including cancer, as death from
cancer may decline at very old age. In elderly subjects
practicing regularly moderate exercise training, some
aspects of immunosenescence are attenuated or
improved, both innate immunity and acquired immunity,
as the reduction of memory cells and the increase of
naïve T cells [94,95] increase further the production of
primary antibody response [96].
Conclusion
Life expectancy has dramatically increased over the last
few centuries of human history and it continues to
increase. Before about 2000 BC, the number of births per
year was under 1 million; until roughly 1000 AD annual
global births ran at less than 10 million; only since 1970
have more than 100 million babies been added to the
human population each year [97]. If the chance of surviv-
ing to age 100 is about 1 in 20 million when life expec-
tancy is 20 and about 1 in 80,000 when life expectancy is
40 (a level not reached in Western Europe until the early
19th century), then centenarians must have been exceed-
ingly rare in most countries before the modern era. The
identification of a Black Swan Event, basing on Taleb’s
criteria, includes that the event is a surprise, the event
has a major impact and after the fact, the event is ratio-
nalized by hindsight, as if it had been expected [1]. The
Black Swan event is isolated and unpredictable. One
naturally tends to give a retrospective justification of his
appearance to make it less random than it actually is.
Unless there is some secret of longevity that has enabled
some humans to transcend the death rates that governed
the fate of nearly all their contemporaries, most accounts
of centenarians in earlier centuries must be inaccurate
[98]. In Italy the number of centenarians has risen from
49 in 1921 to 1304 in 1981, to 1660 in 1990, to 4000 in
December 1995 [99,100]. The growth in the number of
centenarians has garnered significant attention over the
past 20 or so years. One study reported Medicare data
indicating that, in 2000, there were 32,920 centenarians
and that, of these, 0.3% were age 110 and older [101].
Furthermore it is estimated that seven in 1,000 people
born at the turn of the last century lived to become
centenarians and that one in 100,000 lived to be 110 or
older [102]. A better understanding of the biochemical
and neuroendocrine determinant of aging has put inter-
ventions on a somewhat more solid scientific foundation
to combat a few of the deleterious consequences of
aging. Many studies are concerned with elucidating the
regulatory mechanisms of aging at the cellular level and
we expect that they will also have practical implications
that translate into real therapeutic interventions in the
coming decades [103]. The centenarians can still be het-
erogeneous enough to warrant careful phenotyping for
the purposes of discovering different potential genetic
and environmental correlates of exceptional longevity. In
addition, there may be distinctive genetic and environ-
mental interactions involved in the exceptional longevity
of men versus women. According to the U.S. Department
of Census, the number of centenarians could cross the 4
million mark by 2050 [104] In the US, the rise in health
care expenditures associated with the rapid increase in
the elderly population will likely place additional pres-
sures on the Medicaid and Medicare programs, as well as
private insurers, to control health care costs. Efforts to
control costs will likely have a negative impact on both
the supply of and demand for health workers. Neverthe-
less, the growth of centenarians and even more of super-
centenarians, deserves a detailed evaluation as regards
the enormous social, economic and health impacts. The
high impact of longer lifespans has consisted in the last
years in a gradual alteration of the way individuals want
to spend their time during lives, thus leading to drastic
revision of education, health, employment, retirement
and other policies. The study of centenarians and super-
centenarians had the objective to consider this black
swan to better understand the health, welfare, social and
economic consequences of this phenomenon.
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